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ABSTRACT: Lepidoptera (butterﬂies and moths) make the
six-carbon compounds homoisopentenyl pyrophosphate
(HIPP) and homodimethylallyl pyrophosphate (HDMAPP)
that are incorporated into 16, 17, and 18 carbon farnesyl
pyrophosphate (FPP) analogues. In this work we hetero-
logously expressed the lepidopteran modiﬁed mevalonate
pathway, a propionyl-CoA ligase, and terpene cyclases in E.
coli to produce several novel terpenes containing 16 carbons.
Changing the terpene cyclase generated diﬀerent novel
terpene product proﬁles. To further validate the new
compounds we conﬁrmed 13C propionate was incorporated,
and that the masses and fragmentation patterns were
consistent with novel 16 carbon terpenes by GC-QTOF. On the basis of the available farnesyl pyrophosphate analogues
lepidoptera produce, this approach should greatly expand the reachable biochemical space with applications in areas where
terpenes have traditionally found uses.
KEYWORDS: mevalonate pathway, terpenes, juvenile hormones, homoisopentenyl pyrophosphate, HIPP,
homodimethylallyl pyrophosphate, HDMAPP
With an estimated 55 000 chemical species, terpenoids arethe largest natural products class.1 Terpenoids fulﬁll
many important biological roles including cell wall compo-
nents (sterols),2 quinones in the electron transport chain,3
protein traﬃcking/localization regulators (prenylation),4 sig-
naling molecules (estrogen),5 and bioactive molecules for
interspecies competition.6 In addition terpenoids have
important economic uses as pharmaceuticals (taxol),7 ﬂavors
(linalool),8 fragrances (patchoulol),9 commodity chemicals
(isoprene, limonene)10,11 and biofuels (bisabolane and
isopentanol).12−14
Despite their diversity, terpenoids canonically derive from
isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophos-
phate (DMAPP), interconvertible ﬁve-carbon metabolites
which can combine forming longer prenyl pyrophosphates
(Figure 1A). Each IPP ligation yields a molecule ﬁve carbons
larger, giving the progression of geranyl (ten carbons), farnesyl
(15 carbons), geranylgeranyl (20 carbons) pyrophosphates,
and so on. Terpene synthases can catalyze the conversion of
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prenyl pyrophosphates into diverse terpene scaﬀolds via
carbocation rearrangements and cyclizations, producing a
stunning molecular diversity further magniﬁed by downstream
tailoring enzymes. Despite the tailoring, most terpene back-
bones retain the characteristic 5, 10, 15, etc. carbons.
When necessary, nature uses several strategies to produce
terpene backbones outside the multiple of ﬁve carbon
sequence. The most common strategies are carbon removal
from larger terpene backbones, as in geosmin biosynthesis,15 or
attaching another carbon containing molecule, as in
meroterpenoid biosynthesis such as the bitter acids in Humulus
lupulus L. (hops).16 A comparatively less common strategy
observed in nature uses methyltransferases, which add methyl
groups from S-adenosyl methionine (SAM) to prenyl
pyrophosphate molecules as in 2-methylisoborneol17 or
longestin18 biosynthesis. Recently this SAM-methyltransferase
strategy has been developed to produce novel terpenes. The
strategies diﬀer mostly by methyl incorporation location, and
the prenyl pyrophosphate used as methyltransferase substrate,
with successful examples demonstrated for IPP,19 GPP,20,21
and FPP.22
Lepidoptera employ an alternate strategy to create endocrine
molecules named juvenile hormones (JHs) containing terpene
backbones of 16, 17, and 18 carbons (Figure 1D). Lepidoptera
incorporate the six-carbon building blocks homo-IPP (HIPP)
and homo-DMAPP (HDMAPP) into JHs23 through a
modiﬁed mevalonate pathway. The ﬁrst lepidopteran meval-
onate pathway step condenses propionyl-CoA and acetyl-CoA
(Figure 1B), instead of the canonical two acetyl-CoAs (Figure
1A). The extra methyl from propionyl-CoA is retained through
the lepidopteran mevalonate pathway forming FPP analogues
with 16, 17, and 18 carbons en route to JH biosynthesis
(Figure 1B).
Figure 1. Overview of the canonical mevalonate pathway, the lepidopteran mevalonate pathway, chemical diversity of juvenile hormones, and
plasmid architecture of pJH10, pJH15, pJH20, and pJH39. (A) The canonical mevalonate pathway. The pathway starts with the condensation of
two acetyl-CoA and ultimately produces FPP, an essential metabolite. (B) The lepidopteran mevalonate pathway. Production of FPP analogues for
juvenile hormone biosynthesis begins with the condensation of a propionyl-CoA and acetyl-CoA instead of the usual two acetyl-CoA. The extra
methyl group is shown in red for emphasis. The core enzymes of the lepidopteran mevalonate pathway also produce FPP via the canonical
reactions. (C) Examples of potential sesquiterpenes that could be derived from the lepidopteran FPP analogues. (D) Examples of several
lepidopteran juvenile hormones used as endocrine molecules showcasing some of the diﬀerent locations the extra methyl can incorporate. (E)
Plasmid maps of pJH10, pJH15, pJH20, and pJH39. pJH15, pJH20, and pJH39 only diﬀer in terpene cyclase. Enzyme abbreviations: (HMGS) 3-
hydroxy-3-methylglutaryl-coenzyme A synthase; (HMGR) 3-hydroxy-3-methylglutaryl-coenzyme A reductase; (MevK) mevalonate kinase;
(MevPK) mevalonate phosphate kinase; (MevPPD) mevalonate pyrophosphate decarboxylase; (IDI) isopentenyl diphosphate delta isomerase;
(FPPS) farnesyl pyrophosphate synthase; R1 = H, Me; R2 = H, Me; R3 = H, Me.
ACS Synthetic Biology Letter
DOI: 10.1021/acssynbio.9b00230
ACS Synth. Biol. XXXX, XXX, XXX−XXX
B
Several qualities make the lepidopteran mevalonate pathway
attractive for exploring novel terpene space that synthetic
chemistry struggles to eﬃciently sample (potential examples
Figure 1C). Relatively few FPP analogues can theoretically
produce signiﬁcant chemical diversity by varying a single
enzyme, the terpene cyclase. In a previous work terpene
cyclases have successfully cyclized chemically synthesized
prenyl pyrophosphate analogues similar to the lepidopteran
FPP analogues.24 To our knowledge, only three non-JH
terpenes likely incorporate propionate in nature. Though their
full biosynthetic pathways remain unknown, 3-methyl-α-
himachalene, a Lutzomyia longipalpis (sandﬂy) sex phero-
mone25 has 16 carbons, and homofarnesene and bishomo-
farnesene, Myrmica Ants trail pheromones,26 have 16 and 17
carbons, respectively. For these technical reasons, and the
potential medicinal and industrial uses novel terpenes oﬀer, we
investigated novel terpene production in E. coli using the
lepidopteran mevalonate pathway paired with various terpene
cyclases.
■ RESULTS AND DISCUSSION
Lepidopteran Mevalonate Pathway Enzyme Biopro-
specting and Plasmid Design. Lepidoptera have only one
apparent enzyme for each mevalonate pathway step except the
thiolase and FPP synthase steps.27 The two FPP synthases
from the lepidoptera Choristoneura fumiferana (eastern spruce
budworm) have been previously expressed recombinantly and
puriﬁed from E. coli, thus we selected them.28,29 It was noted
that combining puriﬁed cfFPPS1 and cfFPPS2, thought to
form a heterodimer, increased FPP analogue production in a
previous work28 so our designs express both enzymes
concurrently. For the remaining mevalonate pathway enzymes
we selected those predicted by Kinjoh et al. from the
lepidopteran Bombyx mori (silkworm).27 Finally we selected
the well-characterized terpene cyclase epi-isozizaene syn-
thase.30
The predicted Bombyx mori thiolase did not express in E.
coli, so we used the well-characterized thiolase PhaA from
Acinetobacter strain RA3849.31 Soluble expression of the
Bombyx mori 3-hydroxy-3-methylglutaryl-coenzyme A
(bmHMGR) required truncating the membrane-associated
N-terminal domain, similarly required for the S. cerevisiae
HMGR homologue overexpression in other work.32
We cloned the genes into two plasmids named pJH10 and
pJH15 based on plasmids pBbA5c-MevT(CO)-T1-MBIS(CO,
ispA)12 and pBbE1a-GPPS-LS,11 respectively. Annotated
genbank ﬁles for the plasmid are supplied on the JBEI ICE
open registry (see Supporting Information).33 Brieﬂy, pJH10
expresses the ﬁrst mevalonate pathway section, from thiolase to
isopentenyl-pyrophosphate isomerase, on a medium-copy
plasmid (Figure 1E). pJH15 has the two FPP synthases and
epi-isozizaene synthase driven by a strong promoter on a high
copy plasmid (Figure 1E).
Heterologous Pathway Expression in E. coli and
Small Molecule Analysis. We used the E. coli expression
strain Bap1 because it lacks propionate catabolism and has a
strong T7 inducible promoter driving the genomic propionyl-
CoA synthetase (prpE).34 We grew E. coli Bap1 cells harboring
both pJH10 and pJH15 plasmids in sodium propionate
supplemented Terriﬁc Broth medium. At induction we
reduced the temperature to 18 °C to aid correct folding of
the lepidopteran enzymes and added a nonane overlay to
continuously extract terpenes into the hydrophobic layer. After
36 h we harvested cell pellets for proteomic analysis and the
overlay for gas chromatography−mass spectrometry (GC−
MS) small molecule analysis. Proteomics conﬁrmed protein
expression, ﬁnding all pJH10 and pJH15 proteins expressed in
E. coli Bap1 cells (Figure S2−S5) above the no plasmid
control. In the nonane overlay several new peaks with m/z =
218 molecular ions were observed, consistent with novel
C16H26 terpenes (Figure 2A). Replacing pJH15 with the
control plasmid pBbE1a-RFP35, which encodes red ﬂuorescent
protein rather than the FPP synthases and a terpene cyclase,
Figure 2. GC−MS traces of nonane overlays of Bap1 E. coli cells expressing the lepidopteran mevalonate pathway and a terpene cyclase. Plasmid
pJH10 contains the core enzymes of the pathway up to but not including the FPP synthases or a terpene cyclase. Plasmid pJH15, pJH20, and
pJH39 all express the FPP synthases and a single terpene cyclase, either epi-isozizaene synthase (A), α-humulene synthase (B), or a N-terminal
maltose binding protein (MBP) fusion to γ-humulene synthase mutant S484A, Y566F (C). Plasmid pBbE1a-RFP expresses only RFP as a negative
control. Fermentations were conducted with either no propionate, 12C propionate, or singly labeled 13C propionate at 1 g/L. Traces show selected
ion monitoring (SIM) of m/z = 218 for no propionate and propionate conditions, while m/z = 219 is used for singly labeled 13C propionate
conditions.
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abolished the new peaks, as did sodium propionate omission.
When feeding 13C propionate, singly labeled at the carboxylic
acid position, a corresponding +1 m/z parent ion mass shift
(Figure 2A) was seen in the novel compounds via GC−MS.
We then tested if alternate terpene cyclases could also
produce C16H26 terpenes. We built additional plasmids pJH20
and pJH39 based on pJH15, replacing epi-isozizaene synthase
with, respectively, the alternate terpene cyclases α-humulene
synthase from Zingiber zerumbet (bitter ginger)36 and γ-
humulene synthase mutant S484A, Y5660F,37 from Abies
grandis (grand ﬁr). The γ-humulene synthase mutant was
expressed as a maltose binding protein (MBP) fusion to aid
solubility (Figure 1E). These terpene cyclases also produced
novel peaks compared to the RFP control (Figure 2B,C), with
each synthase producing a distinct product proﬁle. All the
novel peaks elute oﬀ the GC column after the sesquiterpene β-
caryophyllene, consistent with the novel peaks having a higher
molecular weight than this 15-carbon standard. Although
theoretically possible, we could not conﬁrm novel peaks
consistent with 17 or 18 carbon terpenes.
To further investigate these novel compounds we scaled up
our best producing strain (Bap1 pJH10 pJH15) to 500 mL
culture volume with a 50 mL nonane overlay. After expressing
per the usual protocol, we concentrated the nonane to
approximately 100 μL using a rotary evaporator under reduced
pressure. We then analyzed the samples with high-resolution
GC-QTOF mass spectrometry. We conﬁrmed the novel peaks
have precursor and fragment ions consistent with C16H26
terpenes. The heaviest predicted ion has a m/z = 218.2029
(Figure 3A). The 203.1794 m/z fragments correspond to 16
carbon terpenes with loss of a methyl group. Similarly, the
189.1638 m/z fragments correspond to an ethyl group loss and
175.1481 m/z to a propyl group loss (Figure 3B).
The mass error of the novel terpenes parent ion on the GC-
QTOF was 3.2 ppm for peak A, 1.37 ppm for peak B, and
−0.92 ppm for peak C with an average error of 1.83 ppm over
the three. We estimated the mass error across the observed
fragmentation patterns against the theoretical fragmentations
from m/z = 218.2029, 203.1794, 189.1638 down to m/z
91.054 (loss of nine carbons). The average mass error was
found to be 2.11 ppm for peak A, 1.28 ppm for peak B, and
1.05 ppm for peak C, with an average of 1.48 ppm between the
three. A 5 ppm mass error is generally considered good for
conﬁrming a molecular formula, and 3 ppm is excellent.38
Given these data, we conﬁrm that the novel compounds have a
molecular formula of C16H26.
Estimating the novel compound titers is diﬃcult because
standards are not commercially available, nor have we
successfully puriﬁed the novel compounds to homogeneity. A
rough estimate can be made using the model sesquiterpene β-
Figure 3. GC-QTOF MS assays of novel terpenes produced by Bap1 pJH10 pJH15 cells. (A) Total ion chromatogram of concentrated nonane
overlay of Bap1 E. coli cells expressing the lepidopteran mevalonate pathway and an epi-isozizaene synthase from plasmids pJH10, pJH15. (B)
Fragmentation patterns of selected chromatographic peaks. Fragmentation patterns were averaged over the whole chromatographic peak. Ions
consistent with C16H26 fragmentation have a predicted m/z of 218.2029, 203.1794, 189.1638, and 175.1481 corresponding to the loss of an
electron, a methyl group, an ethyl group, and a propyl group, respectively. Fragmentation patterns for the other chromatographic peaks can be
found in the Supporting Information, Data Set S1.
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caryophyllene as a standard, but we stress the error in this
crude estimate is hard to know a priori. Bearing in mind this
caveat, we estimate that the combined C16H26 fraction for
pJH15, pJH20, pPJH39 per liter of cell culture to be 0.684 mg
± 0.143 mg (SD), 0.081 mg ± 0.007 mg, and 0.398 mg ±
0.042 mg, respectively.
We then tested if the lepidopteran mevalonate pathway
uniquely accepts propionyl-CoA into higher terpenes, or if the
phenomenon is more general. We used the plasmid pBbA5c-
MevT(CO)-T1-MBIS(CO, ispA),12 which expresses the
Saccharomyces cerevisiae mevalonate pathway genes, and
replaced the thiolase with PhaA from pJH10 to form
pJH122. We cotransformed pJH122 with pJH15 into Bap1
and performed expressions as before. Concurrently we also
assayed sesquiterpene (m/z = 204) vs homosesquiterpene (m/
z = 218) production using the previous plasmid combinations
to compare the percentage of novel terpenes versus the total
terpene content, heeding the aforementioned caveat about
diﬃculties of estimating concentrations without standards.
Surprisingly, we found that Bap1 pJH122 pJH15 produced
0.16 mg/L ± 0.12 mg/L (SD) novel homosesquiterpenes,
about 16% as much as Bap1 pJH10 pJH15, which produced
1.05 mg/L ± 0.219 mg/L in this experiment. We found that
Bap1 pJH10 paired with pJH15, pJH20, and pJH39 made
3.31% ± 0.88%, 5% ± 1.93%, and 11.25% ± 5.93%
homosesquiterpenes, respectively (Figure 4), while Bap1
pJH122 pJH15 made 0.67% ± 0.30%.
■ DISCUSSION
Although terpenoid compounds containing a non-multiple of
ﬁve carbons are promising for pharmaceuticals, ﬂavors,
fragrances, commodity chemicals, and fuels, historically
eﬃciently sampling this space has been diﬃcult. In this
paper we developed a homosesquiterpene diversity platform
that can explore this novel chemical space. The most
immediate application is sesquiterpene drug diversiﬁcation.
For instance, emerging resistance to the sesquiterpene
antimalarial drug artemisinin will require new drug develop-
ment to combat and underscore the importance of methods
like ours which generate new analogues and eventually drug
leads.39
Several methods conﬁrmed the novel chemicals we
produced here as homosesquiterpenes. The chromatographic
peaks incorporated 13C propionate (parent ion +1 m/z shift
compared to 12C propionate), revealing that the extra carbon
originates from propionate as predicted. Unsurprisingly,
propionate omission abolished the novel chromatographic
peaks, as did replacing the terpene cyclase plasmid with an
RFP expressing plasmid. Replacing epi-isozizaene synthase
with alternate terpene cyclases generated novel product
proﬁles demonstrating that this pathway can potentially
generate large chemical diversity with predictable and minimal
alterations.
We initially tried purifying the novel terpenes from the best
producing strain (Bap1 pJH10 pJH15) for nuclear magnetic
resonance (NMR) analysis but separating them from the
nonane overlay and each other proved technically challenging.
This is unsurprising as the novel terpene content compared to
total terpene content was modest at 11.25% ± 5.93% (SD) in
the best-case scenario for Bap1 pJH10 pJH39 and only 3.31%
± 0.88% for Bap1 pJH10 pJH15, which produced our best
titer. Therefore, we used GC-QTOF to validate the new
molecules’ chemical formulas, albeit without the atomic spatial
conﬁguration. We observed the parent ions (average mass
error of 1.83 ppm) and the fragmentation ions (average mass
error of 1.48) in great agreement with the predicted m/z. Five
ppm mass error is generally considered good, and 3 ppm is
excellent for GC-QTOF. This conﬁrmed the novel molecules
exact composition as C16H26 and thus homosesquiterpenes.
We found that the pathway can accept dissimilar terpene
cyclases and still produce novel compounds, a beneﬁcial
property for terpene cyclase library screening. Epi-isozizaene
synthase and α-humulene synthase canonically produce very
narrow product proﬁles,30,40 while γ-humulene synthase
mutant S484A, Y566F has a much broader product proﬁle.37
The three terpene cyclases also catalyze various degrees of FPP
cyclization, with epi-isozizaene synthase producing a tricyclic
compound, γ-humulene synthase mutant S484A, Y566F
primarily making a variety of tricyclic compounds, and α-
humulene synthase primarily making a monocyclic compound.
Despite these diﬀerences in 15 carbon product proﬁle, all made
many 16 carbon products. Given JH natural diversity (Figure
1D),41 extending the strategy to 17 and 18 carbon terpenes
should be possible, although we did not conﬁrm their
production here.
We expected only the lepidopteran mevalonate pathway to
uniquely make homosesquiterpenes. However, we found the S.
cerevisiae core mevalonate pathway enzymes, from HMGR to
IDI, could incorporate propionyl-CoA when paired with an
appropriate thiolase, the lepidopteran FPP synthases, and a
terpene cyclase. However, the lepidoptera pathway counterpart
made 6.6 times as much homosesqiterpenes as the S. cerevisiae
pathway. The lepidopteran pathway also showed better
speciﬁcity toward homosesqiterpenes than the S. cerevisiae
pathway. A few known compounds from ants26 and other
insects closely related to lepidoptera25 hint that the mevalonate
pathway incorporation of propionyl-CoA might not be strictly
limited to lepidoptera. However, it is surprising that the
mevalonate pathway from the much more divergent S.
cerevisiae accepts propionyl-CoA. Perhaps more eﬀort is
justiﬁed in searching the canonical mevalonate pathway in
nature for noncanonical terpenes.
Figure 4. Percentage of total terpenes that are C16H26 terpenes
(C16H26/(C16H26 + C15H24)) produced by various strains. Error bars
represent standard deviation of biological triplicates, except for Bap1
pJH122 pJH15, where the error bar represents nine biological
replicates. N.D. indicates that neither sesquiterpenes nor homo-
sesquiterpenes were detected.
ACS Synthetic Biology Letter
DOI: 10.1021/acssynbio.9b00230
ACS Synth. Biol. XXXX, XXX, XXX−XXX
E
Recently, a SAM methyltransferases strategy adding methyl
groups to prenyl pyrophosphates has enabled novel terpene
production, including sesuiterpenes.19−22 The SAM methyl-
transferase strategy is complementary to the promiscuous
mevalonate pathway because these two approaches incorporate
methyl groups at diﬀerent locations. The SAM methyltransfer-
ase strategy is ATP intensive as SAM regeneration requires
hydrolyzing three high-energy phosphate bonds.42 The
promiscuous mevalonate pathway does not require additional
ATP compared to making traditional terpenes, but the
propionyl-CoA need will require additional engineering to
biosynthesize the material from popular carbon sources if the
end application is making inexpensive commodity chemicals
and fuels.
To our knowledge this work is the ﬁrst report using the
lepidopteran mevalonate pathway to heterologously produce
novel 16 carbon terpenes, unlocking new space in the
economically important terpenes compound class.
■ METHODS
Chemicals. Chemicals were ordered as follows: nonane and
sodium propionate from Alfa Aesar; DpnI and T4 DNA ligase
(5 Weiss U/μL) from Thermo Scientiﬁc; molecular grade
BSA, type IIS restriction enzyme BsaI, and Gibson Assembly
Master Mix from New England BioLabs; TB dry powder from
EMD Millipore; IPTG from Fisher Scientiﬁc; glucose from
VWR Analytical; all other chemical reagents, including 13C
sodium propionate, from Sigma-Aldrich. Qiagen QIAquick Gel
Extraction Kits/PCR Puriﬁcation kits, Zymo Research DNA
Clean and Concentrator Kits and Millipore nitrocellulose
0.025 μM VSWP dialysis membranes were used for DNA
manipulations.
DNA Synthesis and Sources. DNA encoding bmHMGS,
bmHMGR, bmMevK, bmMevPK, bmMevPPD, bmIPPI, and
cfFPPS1 was codon optimized (Genescript) for E. coli,
synthesized, and cloned by Genescript into pET29b+ vector
between the NdeI and XhoI cut sites harboring a TEV protease
sequence before a C-terminal 6xHis tag. The amino acid
sequences for “bm” constructs originate from Bombyx mori
(silkworm), and those for “cf” from Choristoneura fumiferana
(eastern spruce budworm). We sourced the thiolase PhaA
from Acinetobacter strain RA3849 plasmid pMMB-pha.31 Epi-
Isozizaene synthase from Streptomyces coelicolor A3(2) was
codon optimized using GeneDesign43 and synthesized by IDT
as a gBlock. The cfFPPS2 native sequence was ordered
through IDT as a gBlock.44
PCR and Plasmid Assemblies. Primers for DNA
ampliﬁcation and construction were designed using DeviceE-
ditor45 and/or j546 and are listed in Data set S1. Touchdown
PCR was used to amplify DNA fragments for plasmid
construction of pET28cfFPPS2, pET28scEpiisozizaene,
pET29bmHMGRt, pJH10, pJH15, pJH20, and pJH39. iProof
was used as the polymerase using the manufacturer’s
recommended buﬀer conditions with the addition of 5%
dimethyl sulfoxide (DMSO). The PCR reaction cycle was as
follows: 98 °C incubation for 30 s for one cycle. Ten cycles of
98 °C for 10 s, annealing temperature (various, see Data set
S1) for 15 s, decreasing 0.5 °C each cycle, then an extension
time of 22.5 s per kilobase at 72 °C. Then 25 cycles starting
with 98 °C for 10 s, a constant annealing temperature 5 °C
lower than the initial annealing temperature for 15 s, then an
extension time of 22.5 s per kb at 72 °C. One ﬁnal extension
step of 10 min at 72 °C was included at the end of the cycle
before the samples were chilled to 4 °C.
PCR products were puriﬁed via a QIAquick PCR
Puriﬁcation kit, eluted with supplied EB buﬀer, DpnI digested
at 37 °C for 1 h, followed by gel electrophoresis on a 0.5%
agarose gel using GelGreen nucleotide stain. Gel imaging was
done with an Invitrogen Safe Imager. DNA bands of the
correct size were excised and puriﬁed via a QIAquick Gel
Extraction kit, then concentrated to 10 μL using a Zymo
Research DNA Clean and Concentrator kit. DNA concen-
tration was measured using a NanoDrop at 260 nm.
Gibson Assembly was used to construct plasmids
p ET 2 8 c f F P P S 2 , p E T 2 8 s c E p i i s o z i z a e n e , a n d
pET29bmHMGRt47 using Gibson Assembly Master Mix
purchased from New England Biolabs. Equal molar amounts
of inserts and backbone were added and incubated at 50 °C for
1 h. One μL of reaction mixture was then electroporated using
Electromax DH10B and plated on an appropriate antibiotic.
Compared to the full length sequence of bmHMGR, the ﬁrst
390 amino acids of bmHMGRt were truncated, yielding
MKKRPMV··· as the translational start of the protein based on
structural intuition from the human HMGR1 crystal structure
2Q6B.48
pJH10 and pJH15 were constructed using Golden Gate
Assembly49 using the BsaI enzyme. Assembly reaction
conditions consisted of 0.33 μL of BsaI, 0.33 μL of T4 DNA
ligase, 0.05 μL of BSA, 0.5 μL of 10× T4 ligase buﬀer, 33 ng of
backbone, and the other assembly pieces were added in
equimolar concentration to the backbone. Water was then
added to 5 μL total volume. The assembly mixture used a
thermocycling protocol of 45 °C for 2 min, 16 °C for 5 min,
cycled 25 times, followed by 50 °C for 5 min, 80 °C for 5 min,
and 4 °C until samples were recovered from the PCR blocks.
pJH15 was used as the template to produce pJH20 and
pJH39 via Golden Gate Assembly. The epi-isozizaene synthase
from pJH15 was replaced with the terpene cyclases α-
humulene synthase from Zingiber zerumbet (bitter ginger)
from plasmid pTrcHumulene (expressing ZSS1) for pJH20.36
A N-terminal Maltose Binding Protein (MBP) fusion from
pET28a-MBP (previously unpublished plasmid made by Dr.
Andrew Hagen, Ph.D.) was cloned in front of a γ-humulene
synthase mutant S484A, Y566F from Abies grandis (grand ﬁr)
from plasmid pTrcHUM_Y566F_484A (AYG from Table 1)37
for pJH39. Plasmids will be available upon request from the
authors or Addgene.
Plasmid Conﬁrmation via MiSeq Sequencing. Plasmid
deep sequencing was performed as in previous work.50
E. coli KCM Competent Cell Preparation. Competent
cells were prepared starting from a single colony or glycerol
stock on day 1 into an LB overnight. On day 2 the overnight
was diluted 1:100 into 50 mL of LB and grown at 37 °C
shaking at 200 rpm or higher to an OD 600 of 0.35 as
measured with a Beckman Coulter DU800 spectrophotometer.
Cells were then chilled on ice for 20 min before centrifugation
at 8000 rcf for 8 min. The supernatant was decanted, and cells
were resuspended in 5 mL of ice-cold sterile-ﬁltered TSS (LB
base with 10% PEG 3350 (w/v), 5% DMSO (v/v), 20 mM
MgCl2). A 100 μL sample of TSS and cell mixture was then
aliquoted and used immediately or ﬂash frozen using liquid
nitrogen and then stored at −80 °C until use.
One microliter of each desired plasmid was added to the
TSS cell mixture and mixed with 100 μL of sterile 2× KCM
(0.2 M KCl, 0.06 M CaCl2, 0.1 M MgCl2) and incubated on
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ice for 20 min. Cells were then heat shocked at 42 °C for 90 s
before being recovered with 200 μL of TB at 37 °C for 1 h.
Cells were then plated onto LB agar plates with appropriate
antibiotics (carbenicillin at a ﬁnal concentration of 100 μg/mL,
and chloramphenicol at a ﬁnal concentration of 25 μg/mL).
E. coli Pathway Expressions. Freshly transformed
colonies were placed into 10 mL of Terriﬁc Broth medium
(yeast extract 24 g/L, tryptone 20 g/L, glycerol 4 mL/L, 17
mM KH2PO4, 72 mM K2HPO4) with 0.4% glucose and
incubated shaking overnight in glass test tubes. Cells from
overnight samples were diluted 1:100 into fresh TB with 0.4%
glucose and 1 g/L sodium propionate (unlabeled or 1-13C
labeled). Cells were grown at 200 rpm and 37 °C until an
OD600 of 0.8. IPTG was then added to a ﬁnal concentration
of 1 mM and a nonane overlay was added. Temperature was
reduced to 18 °C and the cells were incubated for 36 h in small
scale experiments, and 30 h for the large scale experiment
before harvesting. For small scale expressions, the culture
volume was 10 mL in glass test tubes with 1 mL nonane
overlay, and large scale expressions were done at 500 mL in
baﬄed ﬂasks with 50 mL nonane overlay.
Small Scale Samples. A 1.4 mL aliquot of the nonane/
culture emulsions was harvested and centrifuged at 18000 rcf
for 1 min to separate the organic layer. Then, 100 μL of the
organic layer was collected, and 1 μL was analyzed directly by
GC−MS. Samples were stored at −20 °C for short-term (1 to
2 days), or at −80 °C in amber glass vials if longer term storage
was necessary.
Large Scale Enrichment. The cell culture was added to a
separation funnel and allowed to sit until the overly and a
foamy layer separated from the aqueous layer. The aqueous
layer was removed, leaving a foamy layer and an organic layer.
These layers were washed with approximately 200 mL of NaCl
saturated water. After the layers separated the aqueous layer
was removed. This wash step was repeated one time. The
foamy layer and organic layer were put into 50 mL conical
tubes and spun at 10000 rcf for 3 min. After centrifugation the
foamy layer was greatly reduced and instead a white “goopy”
layer appears between the organic layer and aqueous layer. The
organic layer was then transferred to a round bottomed ﬂask,
and a rotary evaporator was used under reduced pressure to
concentrate the sample to approximately 100 μL. This liquid
was sent through a glass wool mesh to remove any particulate.
Samples were stored at −80 °C or on dry ice under a nitrogen
atmosphere until analysis.
GC−MS Analysis Method. Samples were run on an
Agilent 6890 GC and Agilent 5973 MS using a 30-m DB-5 ms
column with a helium ﬂow of 1 mL/min. The GC was run in
splitless mode with a constant inlet temp and transfer line
temp of 280 °C. The oven starting temperature was 100 °C
held for 1 min. The temperature was increased at 20 °C per
minute until 160 °C. Then the temperature was increased at 10
°C per minute until 225 °C. Then the temperature was
increased at 30 °C per minute until 300 °C where it was held
for 2 min. Single ion monitoring was carried out at 218 or 219
m/z as appropriate to detect 12C or 13C labeled products. A
relative gain factor of 2 was used. Data was analyzed via
Chemstation Enhanced Data Analysis program. For peak
integration the RTE integrator was used.
GC−QTOF Analysis Method. Accurate mass GC−QTOF
data were collected on an Agilent 7890A GC coupled to an
Agilent 7200 QTOF mass spectrometer (Agilent Technologies,
CA, USA). For chromatographic separation, a Restek RTx-5Sil
MS column (30 m × 0.25 mm, 0.25 μm; Restek Corporation,
PA, USA) was used with helium (99.999%; Airgas, PA, USA)
ﬂow maintained at 1 mL/min. Oven temperature started at 60
°C for 1 min, increased at a rate of 10 °C/min to 325 °C and
held constant for 9.5 min, with a transfer line temperature of
270 °C. Spectra were collected over a range of 50−800 m/z at
a rate of 5 spectra per second for electron ionization (EI). The
source was maintained at 230 °C, with 70 eV electron energy.
The transfer line temperature was 270 °C. Data were analyzed
using MassHunter Qualitative Analysis software (Agilent
Technologies, CA, USA).
Proteomics. Cells were grown as in the expressions above.
Then, 20 OD mL of cells was collected, and proteomics was
carried out essentially as described in a previous work.51
Brieﬂy, lysis of E. coli cell pellets combined with protein
precipitation was achieved by the addition of 80 μL of
methanol, 20 μL of chloroform, and 60 μL of water, with
vortexing. The samples were centrifuged at 20 817g for 1 min
for phase separation. The hydrophilic methanol and water
(top) layer was removed, and then 100 μL of methanol was
added, and the sample was vortexed brieﬂy followed by
centrifugation for 1 min to isolate the protein pellet. The
protein pellet was resuspended in 100 mM ammonium
bicarbonate with 20% methanol and quantiﬁed by the Lowry
method. A total of 100 μg of protein was reduced by adding
tris 2-(carboxyethyl) phosphine (TCEP) to a ﬁnal concen-
tration of 5 mM, alkylated by adding iodoacetamide at a ﬁnal
concentration of 10 mM, and digested overnight at 37 °C with
trypsin at a ratio of 1:50 (w/w) trypsin/total protein.
Peptides were analyzed using an Agilent 1290 liquid
chromatography system coupled to an Agilent 6460QQQ
mass spectrometer (Agilent Technologies, Santa Clara, CA)
operating in MRM mode. Peptide samples (10 μg) were
separated on an Ascentis Express Peptide ES-C18 column (2.7
μm particle size, 160 Å pore size, 50 mm length × 2.1 mm i.d.,
60 °C; Sigma-Aldrich, St. Louis, MO) by using a chromato-
graphic gradient (400 μL/min ﬂow rate) with an initial
condition of 95% Buﬀer A (99.9% water, 0.1% formic acid)
and 5% Buﬀer B (99.9% acetonitrile, 0.1% formic acid) then
increasing linearly to 65% Buﬀer A/35% Buﬀer B over 5.5 min.
Buﬀer B was then increased to 80% over 0.3 min and held at
80% for 2 min followed by ramping back down to 5% Buﬀer B
over 0.5 min where it was held for 1.5 min to re-equilibrate the
column for the next sample. The data were acquired using
Agilent MassHunter, version B.08.02, processed using Skyline
version 4.1, and peak quantiﬁcation was reﬁned with mProphet
in Skyline. All data and skyline ﬁles are available via the
Panorama Public repository at this link: https://panoramaweb.
org/Heterologous-Lepidopteran-Mevalonate-Pathway.url.
Data are also available via ProteomeXchange with identiﬁer
PXD012697.
Method for Novel Terpene Titer Estimation. Estimat-
ing titers of the homoterpene compounds is diﬃcult because
we cannot buy standards, nor have we been able to successfully
purify them to homogeneity. To make rough estimates we used
β-caryophyllene as a standard. However, we stress the error in
this estimate is hard to know a priori as we must assume the
novel terpenes ionize like the parent ion of β-caryophyllene. A
1 μL aliquot of β-caryophyllene was diluted into 99 μL of ethyl
acetate (or in another instance 9 uL of ethyl acetate). This
mixture was then diluted 1.5 μL into 1500 μL of ethyl acetate
yielding a vial of 0.01 μL of β-caryophyllene per milliliter of
ethyl acetate (or 0.1 μL of β-caryophyllene per milliliter of
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ethyl acetate in another instance). A 750 μL aliquot of this
mixture was serially diluted to generate the standard curve. The
standard curve was run from the smallest concentration vial to
the vial with highest concentration using GC−MS in single ion
monitoring mode detecting m/z = 204. β-Caryophyllene
density was taken to be 0.9052 g/cm3 at room temperature
(co l l e c t ed f rom ht tp s ://en .w ik iped i a .o rg/w ik i /
Caryophyllene).
To estimate the purity of β-caryophyllene, a sample of 0.01
μL of β-caryophyllene per milliliter of ethyl acetate (or 0.1 μL
of β-caryophyllene per milliliter of ethyl acetate in another
instance) was analyzed using scan mode on the GC−MS
instrument. The sample contained primarily β-caryophyllene
but also some amount of two oxidized β-caryophyllene
compounds. By taking the ratio of the peak areas we concluded
that the standard was 94.4% β-caryophyllene, and 5.6% other
compounds (and in another instance using new β-caryophyl-
lene, 97.4% and 2.62% other compounds). The Excel function
LINEST was used to generate an equation to convert peak area
to mg/L. We then corrected for the purity of our β-
caryophyllene standard.
To estimate the homosesquiterpene peak areas we averaged
the 12C propionate and 13C propionate fermentation runs, each
in biological triplicate thus representing six observations from
Data set_S1.
Method for Novel Homosesquiterpene to Total
Terpene Fraction Estimation. Peak areas for homosesui-
terpene were gathered at m/z = 218, and for sesquiterpenes at
m/z = 204. These areas were then converted into the percent
C16H26 terpenes compared to total terpenes (C16H26PeakArea/
(C16H26PeakArea + C15H24PeakArea)) within a biological
replicate. The biological triplicate was used except for pJH122,
which used nine replicates.
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